Other languages Femasys Inc.

Equities

FEMY

US31447E1055

Real-time Estimate Cboe BZX Other stock markets 01:46:40 2024-05-22 pm EDT			5-day change	1st Jan Change
1.3 ^USD	+1.56%		-2.26%	+33.33%

May. 09	Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09
Femasys Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
Femasys Inc. Announces Positive Topline Data from Pivotal Trial for Its Fda-Cleared Femaseed®? for the Treatment of Infertility	Mar. 20
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution	Mar. 06
Femasys Inc. Appoints Richard Spector as Chief Commercial Officer	Feb. 06
Femasys Begins Patient Enrollment for Permanent Birth Control Candidate Trial	Jan. 26
Femasys Inc. Begins Fembloc Pivotal Trial Enrollment At UC Davis Medical Center, A Hub for Innovation and Groundbreaking Research in Health Care for Women	Jan. 26
Femasys Inc. Begins Fembloc Pivotal Trial Enrollment At University of Utah	Jan. 23
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine	Dec. 15
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer	Nov. 30
Femasys Inc. Completes Enrollment of Femaseed Pivotal Trial in Support of Commercial Launch	Nov. 29
Femasys Inc. Appoints Joshua Silverman as Director	Nov. 21
Femasys Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Femasys Inc. Successfully Completes the Stage 2 European Union (EU) Medical Device Regulation	23-10-26
Top Premarket Decliners	23-10-04
Top Midday Gainers	23-09-29
Top Midday Decliners	23-09-27
Femasys Activates Enrollment in Trial of FemBloc Birth Control Candidate	23-09-27
Femasys Inc. Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site to Participate	23-09-27
Top Premarket Decliners	23-09-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Femasys Inc.

Equities

FEMY

US31447E1055

Other languages

Filters